Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Visit One News Page for Health Insurance news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Health Insurance news headlines.
    0 0

    A 'secret' patch shows the future of treating the most common food allergy, and two biotechs are competing to own the $3 billion market (AIMT, DBVT)· 2019 could be the year of the first treatments for kids with peanut allergies.
    · Two companies are competing for a market of around $3 billion. Both are seeking approval from US regulators to start selling their products.
    · The treatments aren't a cure, but do reduce the risk of a dangerous allergic reaction to peanuts.
    · Some parents say they prefer one product over the other, but it has a key drawback.

    Josh Mandelbaum, 13, has a secret.

    For five years, a small circular sticker on his back, around the size of a quarter, has contained the very thing that the New Jersey teen is allergic to: peanuts.  

    The patch is part of a growing trend that aims to use triggers like peanuts to help those with allergies. The aim is to desensitize them and act like a kind of guard rail against accidental exposure. 

    You might soon be able to get a prescription for these treatments. The patch and another first-of-its-kind peanut allergy pill could be approved by U.S. regulators as early as next year, and both have the potential to be blockbuster medications.  

    About 15 million people in the U.S. have food allergies to things like milk, eggs and wheat. Peanut allergies are the most common food allergy among kids, and have been on the rise over the last decade. The market for the treatments is huge, and eventually could reach around $3 billion in total sales, according to Stifel analyst Derek Archila. 

    Doctors currently have little to offer patients besides advising them to avoid what they’re allergic to and always carry an EpiPen or product like it to rescue them if they have a life-threatening allergic reaction. Moreover, those with peanut allergies are less likely to outgrow it than other food allergies, and it’s hard to predict how severe an allergic reaction might be.

    *A treatment, not a cure*

    The new approach has worked for Josh, his mother, Lianne Mandelbaum, who is also a food allergy advocate, told Business Insider. Josh first tried out the product, DBV Technologies’ Viaskin Peanut, as part of a clinical trial years ago.

    In the beginning, as part of a “food challenge” used in the trial, Josh had an allergic reaction after eating the equivalent of a fraction of a peanut, Lianne Mandelbaum said. Two-and-a-half years later, it took much more, about one and a half peanuts, to spur a reaction.

    While that may sound like a tiny change, it's made a huge difference in how Josh lives his life. He can now confidently go to school and sit in a cafeteria that serves peanut butter, for instance, his mother said.

    The patch isn’t a cure: Josh continues to avoid peanut products, for example, and has to be careful about accepting food that could be unsafe. But it's been empowering, she said, and given them peace of mind. 

    "I just don’t want him to die from eating the wrong cookies," she said. "We live in a human society. Humans make errors. That’s why you want a safety gap."

    Mandelbaum was so pleased with the results that she fought to let Josh keep using the patch after the trial ended, through an expanded access program. The only side effects he’s seen have been itchy red welts, which have eased over time.

    Josh would wear it for the rest of his life if he has to, she told Business Insider.

    **How it all came together**

    People with allergies are usually advised to keep away from what they’re allergic to.

    But controlled exposure, called immunotherapy, has also been part of allergists’ arsenal of tools for many years now, including through allergy shots for pollen, mold, dust and more.

    Physicians in private practice have also tried this with peanuts and other food allergies. In what’s called “oral immunotherapy treatment,” patients eat small amounts of peanut or another allergen, which increases over time.

    Though these have had success, they aren’t approved by the U.S. Food and Drug Administration and may not be covered by health insurance. And, like other immunotherapy approaches, they have risks, including the chance of an allergic reaction.

    The search for a more standardized approach eventually led to the creation of Aimmune, which is developing AR101, a capsule of peanut protein that is mixed into food.

    When the company was first started, the big question was “how do you take a food, which is inherently variable and highly unpredictable, and make it into a medicine?” Dr. Daniel Adelman, Aimmune’s chief medical officer, explained.

    The company has done that by focusing on peanut protein, which is where the allergens in the nut are, and using that to re-educate the immune system, he said.

    *Seeking FDA approval*

    Dosing of AR101 starts at a very low level, or half a milligram of peanut protein, and then increases over about six months to 300 milligrams, or roughly the equivalent of one peanut kernel. Patients then continue on at that level as a maintenance dose.

    Aimmune aims to file with the FDA this month for approval to treat patients ages 4 to 17; a decision could arrive by early fall of 2019. DBV filed for FDA approval of Viaskin Peanut in October to treat patients ages 4 to 11, with a decision expected next year.

    The products could potentially reduce a life-threatening allergic reaction to a milder one, giving patients, their loved ones and their doctors an added layer of safety, Dr. Purvi Parikh, clinical assistant professor at NYU Langone and a board-certified allergist, told Business Insider.

    If they are found to be safe and effective, they could dramatically change patients’ quality of life, Parikh said, reducing an untold amount of anxiety and stress for them and their families.

    But which company could end up leading the space is more unclear. A group of doctors polled by Stifel's Archila slightly favored DBV’s product, he said, though the analyst also noted that there has been controversy over DBV’s clinical trial data.

    Some parents of children with allergies told Business Insider that DBV’s patch seemed safer to them, because it doesn’t require actually eating an allergen. The company also touts this as a potential benefit on its website, saying that its approach “offers a potentially strong safety profile because of how it works via the skin.”

    *Read more:* An experimental treatment for peanut allergies just succeeded in a key trial

    Tamara Hubbard, a licensed counselor whose nine-year-old son is taking part in an ongoing trial for the patch, called the product “life-changing.” She was initially drawn to it over other options because the process was slower and avoided gastrointestinal side effects, Hubbard said.

    *A giant question mark*

    On the other hand, those on the patch likely won’t know exactly how much allergen they can tolerate, because — absent completing a “food challenge” — they wouldn’t be eating it.

    Which product a family chooses will likely thus depend on their own preferences, Hubbard, who specializes in food allergy counseling, among other things, said.

    Aimmune’s Adelman also emphasized the latter perspective in an interview with Business Insider.

    “I think that the biggest danger to a child who is peanut allergic is going out into the world and thinking they are protected if they’re not,” he said.

    Pricing — another giant question mark hovering overhead — could also be an important factor. The Institute for Clinical and Economic Review, a nonprofit that evaluates drug prices and, is still reviewing the products and plans to release reports on them in the first half of next year. 

    The companies haven't said how much the drugs will cost.

    Parents, meanwhile, said that they hope everyone who wants these products can get them.

    “Everybody who has food allergies deserves to have access to lifesaving treatment,” food allergy advocate Mandelbaum said. “It should be available to everybody.”

    Join the conversation about this story »

    NOW WATCH: This 13-year-old scientist invented a safer way to treat pancreatic cancer, and he hasn't even started high school yet Reported by Business Insider 21 hours ago.

    0 0

    Key certifications make it easier for customers to achieve their own compliance.

    LENEXA, Kan. (PRWEB) December 10, 2018

    Cavern Technologies, a 160,000-square-foot data center in Lenexa, Kansas, has received important compliance certifications, ensuring that their customers remain compliant with their industries’ regulations.

    Cavern demonstrated full compliance with Payment Card Industry Data Security Standard Requirements and Security Assessment Procedures (PCI DSS) and now holds PCI DSS 3.2 certification. This confirms that customers using Cavern’s co-location services meet industry requirements to protect customer card data. Such compliance is invaluable to retail companies and the vendors with which they do business.

    Cavern also secured Health Insurance Portability and Accountability Act (HIPAA) compliance, demonstrating the highest standards in risk assessment, security measures and training. This certification assures customers that co-locating with Cavern keeps patients’ electronic health information safe.

    “Meeting and exceeding industry compliance requirements is a top priority for Cavern Technologies,” said John Clune, CEO of Cavern. “We want our customers to know that working with us means they are compliant and their data is always secure.”

    About Cavern Technologies, Inc.
    Cavern Technologies, Inc. is a leading provider in the development, leasing and operation of build-to-suit wholesale data centers in the Kansas City region. Located 125-feet underground in a 3-million-square-foot facility, Cavern’s environmentally regulated, secure infrastructure is SSAE 18 SOC 1 Type II and SOC 2 Type II certified. Cavern is designed to meet the specialized power, cooling and security requirements companies need to house IT systems that support their mission-critical business processes. Cavern provides tenants with unique business solutions and a value proposition focused on minimizing the total cost of ownership of data center and colocation infrastructure. https://www.CavernTechnologies.com Reported by PRWeb 6 hours ago.

    0 0

    Fuse Networks LLC is pleased to announce that it has chosen Compliancy Group to help satisfy HIPAA compliance.

    SEATTLE (PRWEB) December 10, 2018

    Fuse Networks LLC is pleased to announce that it chosen Compliancy Group to help meet the federally regulated standards of the Health Insurance Portability and Accountability Act (HIPAA).

    Fuse Networks has been providing professional IT Support for businesses in and around the Pacific Northwest since 2009. They strive to give their clients enterprise-level services and solutions at prices that work for small businesses.

    Time and experience have enabled Fuse Networks to build a proactive approach that aligns technology, people, and process to deliver on their promise to their clients. Through that approach, Fuse Networks creates a competitive advantage for their clients, allowing them to focus on their business and not their technology.

    HIPAA is made up of a set of regulatory standards governing the security, privacy, and integrity of sensitive health care data, called protected health information (PHI). PHI is any demographic health care-related information that can be used to identify a patient. If vendors who service health care clients come into contact with PHI in any way, those vendors must be HIPAA compliant.

    Fuse Networks has begun implementing a full compliance program, adhering to the necessary regulatory standards outlined in the HIPAA Privacy Rule, HIPAA Security Rule, HIPAA Breach Notification Rule, HIPAA Omnibus Rule, PCI, and HITECH. Upon completion, the standards will be heavily vetted against the letter of the law and will meet federal NIST requirements.

    "We are excited about our partnership with Compliancy Group. Their web-based application, the Guard, provides our clients with the necessary tools to manage their HIPAA compliance," said Travis Thom, CEO of Fuse Networks LLC. "Through Compliancy Group's six stage process, we are able to validate IT Security policies and procedures are enforced so their patient records stay protected."

    To find out more about Fuse Networks LLC, visit:
    http://www.fusenetworks.com
    http://www.fusenetworks.com/blog

    About Compliancy Group:
    Compliancy Group simplifies HIPAA compliance so that health care professionals can confidently run their practice. The Guard™ is our simple, cost-effective, web-based solution. Users are guided by our team of expert Compliance Coaches™ to Achieve, Illustrate, and Maintain™ total HIPAA compliance. Visit https://www.compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.

    About Fuse Networks LLC:
    At Fuse Networks we become an extension of your business; responding to issues quickly, often before you even know about them. Covering everything from your servers and network infrastructure, to your workstations, applications and cloud services; we provide proactive end-to-end solutions for all your technology needs. Reported by PRWeb 4 hours ago.

    0 0

    Former President Barack Obama is still very much committed to making the Affordable Care Act (also known as ObamaCare) a functional and affordable resource for Americans who need health insurance. On Monday, Obama released a short video clip reminding viewers that the deadline to sign up for 2019 insurance coverage is Friday, December 15th, and he […] Reported by Mediaite 3 hours ago.

    0 0

    Parkview Dental Partners has been formed by BayView Dental Associates and Parkstone Growth Partners to provide dental growth and management services to leading dentists along Florida's Gulf Coast, from Tampa/St. Pete to Sarasota/Bradenton to Venice, and beyond. Parkview is actively seeking likeminded dentists to join the partnership.

    SARASOTA, Fla. (PRWEB) December 10, 2018

    Parkstone Growth Partners (“Parkstone”) and BayView Dental Associates (“BayView Dental”) are pleased to announce the formation of Parkview Dental Partners (“Parkview Dental”), a dentist-founded dental growth and management partnership. Parkview Dental will be led by CEO, Dr. Kenneth Liszewski, founder of BayView Dental, a group dental practice comprised of 16 dentists and hygienists across eight offices who provide general, specialty, and cosmetic dentistry services to patients of all ages.

    Parkview’s mission is to support dentists in providing clinically excellent oral care and a great patient experience, while lifting the daily burdens of practicing such as human resource management, billing & collections, insurance relations, marketing, accounting and other administration.

    “For over 32 years, it has been our mission at BayView Dental to provide the very best dental care, a great patient experience, and a warm and collegial team environment,” said Dr. Liszewski. He continued, “I brought on Parkstone, a healthcare business-building partner, to help establish Parkview Dental because of their experience in supporting other practices and businesses, but more importantly because they share our values and focus on clinical excellence, patient experience, and employee satisfaction.”

    Will Schlotthauer, former Chief Operating Officer of MGA Insurance, and Partner at Parkstone, will serve as Chief Strategy Officer at Parkview Dental responsible for strategic direction, growth, and practice acquisitions and affiliations. “We are thrilled to partner with Dr. Liszewski and the talented dentists, hygienists, and team at BayView Dental. Our alignment of values and vision provide a great foundation for growth. We look forward to supporting a growing family of dentists, hygienists, and team members as we expand our offices and services across Florida’s Gulf Coast.”

    The operating team at Parkview Dental will be led by veteran dental care executive Lisa Woodman, Vice President of Operations. Under Ms. Woodman’s leadership, Parkview Dental will expand its administrative, IT, insurance relations, and patient acquisition support to affiliated dentists and hygienists at a growing number of offices. Dylan Kindler of Parkstone will support Dr. Liszewski, Ms. Woodman and Mr. Schlotthauer as Chief Financial Officer.

    Lou Marinaccio, Managing Partner at Parkstone, added that, “Parkstone is proud to join Dr. Liszewski and the Parkview Dental team in building a new and different kind of dental platform. As a dental growth and management partnership, Parkview will always prioritize clinical excellence, doctor autonomy, and patient experience, while providing exceptional support for our teams to do what they do best: provide great care.”

    Dr. Liszewski concluded, “We look forward to welcoming many new dentists and offices to the Parkview Dental family as we expand to serve our Gulf Coast community. We are confident that our services and partnership will give our dentists, teams, and patients more to SMILE about!”

    About BayView Dental Associates
    For over 32 years, Dr. Kenneth Liszewski and the team at BayView have provided exceptional dental care and a welcoming patient experience for families throughout Sarasota, Bradenton, Venice, and St. Petersburg Florida. BayView’s over 16 dentists and hygienists provide comprehensive dental care with general, specialty, and cosmetic dentistry services to patients of all ages. BayView offers high quality, affordable treatment and a warm and welcoming experience that is a leader in its markets. For more information, please visit http://www.bayviewdental.com.

    About Parkview Dental Partners
    Parkview Dental Partners is a dentist-founded, dental growth and management partnership formed in September 2018 through an affiliation with BayView Dental Associates. Based in Sarasota, Florida, Parkview Dental’s mission is to support leading dentists in providing clinically excellent oral care and a great patient experience by lifting the daily burdens of practicing such as human resource management, billing & collections, insurance relations, marketing, accounting and other administration. Parkview Dental is actively seeking affiliations with likeminded dentists throughout the Gulf Coast of Florida, offering strong practice support, a collaborative team environment, and a path to partnership for qualified dentists. For more information, please visit http://www.parkviewdp.com.

    About Parkstone Growth Partners
    Parkstone Growth Partners (“Parkstone”) is a business-building investment partner focused on providing operating resources and capital to entrepreneurial practices and companies across Healthcare, Insurance, and Healthy Living markets. Parkstone is led by an integrated team of proven senior executives from across our sectors, with a mission to deliver a measurably positive impact on our partner companies. Unlike traditional private equity, we believe that by prioritizing clinical and service excellence, client and patient experience, and values over financial measures, our partner companies will realize their full potential. Current partnerships include Parkview Dental Partners (oral care), AIA Direct (health insurance), and Turnbridge (behavioral health). Our leadership team has been part of the growth of such market leaders as: MGA Insurance Group, Advanced Dermatology and Cosmetic Surgery, Independence Village, Yale Behavioral Health, Johns Hopkins Medical, Warby Parker, Atkins, Naked Juice, and more. For more information, please visit http://www.parkstonegp.com.

    SOURCE: Parkstone Growth Partners Reported by PRWeb 42 minutes ago.

    0 0

    Former President Barack Obama promises no gimmicks this year to stress the importance of signing up for health insurance before Saturday's deadline Reported by CBS News 1 day ago.

    0 0

    Latest 2018 ez1095 ACA software is available for establishments to process in multiple offices in a network version. Test drive the 30 day no cost or obligation trial at halfpricesoft.com.

    PITTSBURGH (PRWEB) December 11, 2018

    Employers and tax professionals that need to process ACA (Affordable Care Act) forms 1095 in multiple offices, are accommodated with a network version for new 2018 ez1095 software from Halfpricesoft.com. ez1095 can process form 1095C, 1094C, 1095B and 1094B. It has also been approved by IRS to generate the efile documents that customers can upload to IRS for ACA form electronic filing.

    ez1095 software also allows customers to import data from external file and makes it easy to print ACA forms for recipients. Priced from just $195 per installation (cost differs with network and efile version). ez1095 can also support multiple company accounts on the same computer at no additional charge.

    “The latest version of ez1095 2018 software will easily accommodate multiple offices or computers when processing 1095 forms with the network version,” said Dr. Ge, the Founder of Halfpricesoft.com.

    Customers that are required to file Form 1095C, 1094C, 1095B and 1094B can download and try out this ACA software from halfpricsoft.com before purchasing with no obligation by visiting https://www.halfpricesoft.com/aca-1095/aca-1095-software.asp.

    The main features include but are not limited to :· Print ACA Form 1095-C, 1094-C, 1095-B and 1094-B on white paper for recipients and IRS with inkjet or laser printer.
    · PDF print 1095-C and 1095-B recipient copies
    · Efile version available at additional cost.
    · Support unlimited companies.
    · Support unlimited number of recipients.
    · Print unlimited number of 1095 and 1094 forms.
    · Fast data import feature
    · Print Form 1095 C: Employer-Provided Health Insurance Offer and Coverage Insurance
    · Print Form 1094 C: Transmittal of Employer-Provided Health Insurance Offer and Coverage Information Returns
    · Print Form 1095-B: Health Coverage
    · Print Form 1094-B: Transmittal of Health Coverage Information Return

    ez1095 software is compatible Windows 10, 8.1, 8, 7, and Vista. ez1095 software’s graphical interface leads customers step-by-step through setting up company, adding employees, add forms and print forms. Customers can also click form level help links to get more details regarding the software.

    To learn more about ez1095 ACA software, customers can visit http://www.halfpricesoft.com/aca-1095/aca-1095-software.asp

    About halfpricesoft.com
    Halfpricesoft.com is a leading provider of small business software, including online and desktop payroll software, online employee attendance tracking software, accounting software, in-house business and personal check printing software, W2, software, 1099 software, Accounting software, 1095 form software and ezACH direct deposit software. Software from halfpricesoft.com is trusted by thousands of customers and will help small business owners simplify payroll processing and streamline business management. Reported by PRWeb 9 hours ago.

    0 0

    Ethiopia aims to achieve universal health coverage (UHC) through primary health care (PHC). This requires a rapid increase in domestic spending on health. Building on almost two decades of effective technical assistance, the new Abt Associates-led USAID Health Financing Improvement Program will support this effort.

    ROCKVILLE, Md. (PRWEB) December 11, 2018

    Having met its Millennium Development Goals for reducing under-5 mortality ahead of schedule, Ethiopia is steadily moving toward better health outcomes. Per capita health spending has been growing consistently, and the share of domestic financing, including government spending on health, has increased. However, as the economy and public sector’s capacity grow, donor funding is gradually decreasing, and the health sector needs to prepare for it. Ethiopia aims to achieve universal health coverage (UHC) through primary health care (PHC). This requires a rapid increase in domestic spending on health. Building on almost two decades of effective technical assistance, the new Abt Associates-led USAID Health Financing Improvement Program will support this effort.

    Abt was recently awarded the USAID Health Financing Improvement Program, a 5-year, $39.6 million project, aimed at supporting the government of Ethiopia (GOE) to further strengthen and institutionalize health financing reforms and initiatives to provide accessible, high-quality PHC services for all Ethiopian citizens with reduced financial barriers. The Program consortium includes core partners Breakthrough International Consultants, Dimagi, the Institute for Healthcare Improvement, Results for Development and resource partner Harvard School of Public Health. The program builds on previous investments in health care financing reform by USAID and GOE. Abt and its partners will work with GOE to:

    -Increase domestic resource mobilization for the enhanced provision of quality PHC services;
    -Streamline the pooling of risk-sharing/insurance mechanisms for wider access to PHC services with reduced financial barriers;
    -Facilitate the strategic purchasing of health services from public and private health providers; and
    -Improve governance, management and evidence-generation for health financing reforms and health facilities.

    By the end of the Program in 2023, Ethiopia’s health sector is anticipated to have more resources available for primary health care services. The share of domestic financing of health care services will increase from 2014’s 64 percent to 70 percent. More people will have insurance coverage, including the poorest. Insurance programs will be made sustainable by connecting the public and the private sectors and promoting improved quality. GOE will employ evidence-based practices that engage the full spectrum of health-sector partners. Abt and its partners will work on purposefully and systematically building local capacity to institutionalize and transition Program responsibilities to these institutions for sustainable and continuous implementation.

    “We’re proud of the work we’ve done with the Ethiopian government to successfully test and scale up community-based health insurance through our previous work conducted under the USAID bilateral Health Sector Financing Reform and the global Health Finance and Governance projects,” said Catherine Thompson, Regional Managing Director with Abt Associates. “We’re excited to take this next step toward Universal Health Coverage with our partners in the government and private sector.”

    About Abt Associates

    Abt Associates is an engine for social impact, dedicated to moving people from vulnerability to security. Harnessing the power of data and our experts’ insights, we provide research, consulting and technical services globally in the areas of health, environmental and social policy, technology and international development. http://www.abtassociates.com Reported by PRWeb 4 hours ago.

    0 0

    Republica Havas selected among PR News’ 2018 Top Places to Work in the industry. PR News editors, together with an outside panel of industry experts, select winners based on the following criteria: opportunities for career development and growth, open communication, unique benefits, compensation, and diversity in the workplace, among others.

    NEW YORK (PRWEB) December 11, 2018

    Republica Havas, one of America’s leading and fastest-growing multicultural creative, media, and communications agencies, was named one of PR News’ 2018 Top Places to Work in the industry. The award was presented at a dinner at the Edison Ballroom in New York, and this year marks the second time the agency receives this recognition.

    PR News receives hundreds of entries from across all the United States, including agencies and Fortune 500 companies. PR News editors, together with an outside panel of industry experts, select winners based on the following criteria: opportunities for career development and growth, open communication, unique benefits, compensation, and diversity in the workplace, among others.

    "Our people are the heart and soul of Republica Havas. We are fiercely committed to providing a familial, collaborative culture where employees feel appreciated and inspired to do their best work as they grow professionally,” said Jorge A. Plasencia, Republica Havas co-founder, chairman and CEO. “Being named a Top Place to Work once again by PR News is definitely a feather in our cap,” added Plasencia.

    As part of its familial culture, Republica Havas offers employees many unique and exciting benefits, including a Barista brewing the agency’s famous cafecito; Breakfast Fridays; a Fitness Center; various games including Pool, Foosball, and Ping Pong; Pet Insurance; Domestic Partner Health Insurance; Birthday Holiday; Summer Fridays; Annual Offsite Retreats; Quarterly Town Hall Meetings; Field Trips; and regular raffles to the best sports, concerts and community events. Additionally, the agency offers regular yoga and meditation practices on its rooftop terrace.

    For a full list of winners, click here.

    About Republica Havas

    Republica Havas is one of America’s leading and fastest-growing multicultural creative, media, and communications agencies. Through its “Rethink Relevant” strategic mantra, Republica Havas provides integrated services including strategy, creative, research, media planning and buying, analytics and consumer science, digital, public relations, social, and experiential to numerous blue-chip clients in the U.S. and markets around the world. Founded in 2006 and based in Miami, Florida, Republica Havas is part of Havas Group, a division of Paris-based Vivendi. For more information, visit republicahavas.com, and follow @RepublicaHavas and #RethinkRelevant on social media. Reported by PRWeb 1 day ago.

    0 0

    Reported by SeekingAlpha 6 hours ago.

    0 0

    WASHINGTON (AP) — Government numbers show health insurance sign-ups for the Affordable Care Act are down with just a few days left to enroll. That's happening even though premiums are stable, consumers have more choice and millions of uninsured people can still get financial help. The sign-up deadline is this Saturday in most states, for coverage beginning Jan. 1. Barring a sign-up surge, the nation's uninsured rate could edge up after a yearslong coverage expansion that has seen about 20 million people get health insurance. A report Wednesday from the Centers for Medicare and Medicaid Services shows nearly 20 percent fewer new customers signed up than at about the same time last year. New customers drive the growth of HealthCare. Reported by SeattlePI.com 4 hours ago.

    0 0

    $3 million subscription contract with potential for expansion

    SAN RAMON, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- WANdisco (LSE: WAND), the LiveData company, is pleased to announce it has secured its largest ever cloud contract with a major US health insurer (the "Client"). The agreement is valued at approximately $3 million and will see the Client deploy the Company's patented Big Data and Cloud product, WANdisco Fusion ("Fusion").The contract is for an initial three-year subscription period valued at $3 million. The Client will start utilising Fusion for on-premise and hybrid cloud use cases. This contract leverages WANdisco’s strategic co-sell relationship with Microsoft as the Client looks to move data to the Azure cloud. The Client, one of the largest health insurers in the US, has substantial data requirements across their 22,000 employees and 15 million members representing a significant opportunity to grow the subscription over time.

    Both hybrid-cloud and cloud migration are LiveData use cases where, in order to take advantage of the significant benefits of cloud, customers must be able to move data without interruption to business operations.

    WANdisco Fusion is the only solution that can enable organisations to seamlessly move large volumes of data with consistent and continuous availability whilst meeting regulatory requirements. WANdisco's patented technology ensures our customers are able to leverage the impact of their IT investment to support exponential data growth without growing the IT budget.

    *David Richards, Chief Executive Officer and Chairman of WANdisco, commented:*

    “I am delighted to announce our largest ever cloud deal. This reflects our continued focus upon predictable recurring revenues. The $3 million contract initially spans three years, but there is significant potential to expand this further to meet their developing data requirements This contract illustrates the significant traction we are gaining in healthcare and other key industries. Our pipeline continues to grow, and we remain confident and excited about our future.”

    “The customer has vast data streams which need to be consistently and continuously available during migration to cloud, hybrid cloud and multi-cloud. WANdisco Fusion remains the only technology capable of fulfilling this. This is an excellent demonstration of how we continue to enable the migration of critical live data at scale for Microsoft Azure, and other cloud leaders.”

    This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

    For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by David Richards, CEO and Chairman.

    *For further information please contact:*

    *WANdisco plc*
    David Richards, Chief Executive Officer and Chairman
    Erik Miller, Chief Financial Officer *via FTI Consulting*
    * * * *
    *FTI Consulting*
    Matt Dixon / Harry Staight / Chris Birt / Kwaku Aning *+44 (0)20 3727 1137*
      * *
    *Stifel (Nomad and Joint Broker)*
    Fred Walsh / Neil Shah / Alex Price / Rajpal Padam *+44 (0)20 7710 7600*
      * *
    *Peel Hunt (Joint Broker)*
    Edward Knight / Nick Prowting *+44 (0)20 7418 8900*
      * *
    *WH Ireland Limited (Joint Broker)*
    Adam Pollock *+44 (0)20 7220 1666*

    *About WANdisco*

    WANdisco is shaping the future of data infrastructure with its groundbreaking Live Data platform, enabling companies to put all their data to work for the business - all the time, at any scale.

    WANdisco makes data always available, always accurate, and always protected, delivering hyperscale economics to support exponential data growth with the same IT budget. With significant OEM relationships with IBM and Dell EMC and go-to-market partnerships with Amazon Web Services, Cisco, Microsoft Azure, Google Cloud, Hewlett Packard Enterprise, Oracle and other industry titans - as well as hundreds of customers among the Global 2000 - WANdisco is igniting a Live Data movement worldwide. Reported by GlobeNewswire 12 hours ago.

    0 0

    DFV: Amazon Alexa now with monthly payments and liability insurance *FRANKFURT AM MAIN / ACCESSWIRE / December 13, 2018 / *The Insurtech DFV Deutsche Familienversicherung AG continues its vision of insurance sales via Amazon Echo and introduces monthly payments. In addition, the insurance portfolio, which is offered through Alexa, as announced in October, also expands.

    Dr. Stefan M. Knoll, CEO of DFV: "Thanks to our flexible, event- and java-basedIT we are able to sell insurance via Amazon Echo. The use of AmazonPay as a payment method is another sign of the company's digital capability. The next step is to offer more and more of our products during Amazon Echo."

    Since this december , the Frankfurt based Insurtech also offers, as first insurance company worldwide, liability insurance via Alexa. So customers can handle the complete conclusion of a liability insurance on Amazon Echo from the advice to the payment.

    *About DFV Deutsche Familienversicherung AG (German Family Insurance)*

    DFV Deutsche Familienversicherung AG (ISIN DE000A0KPM74) was founded in 2007 as an insurance start-up with the aim of offering insurance products that people really need and understand immediately ("simple, sensible"). The Insurtech is known for its award-winning supplementary health insurance (dental, health and nursing care insurance as well as accident and property insurance). With all-digital product design and digital voice assistant connectivity, the company is setting new standards in the insurance industry.

    Further information at: www.deutsche-familienversicherung.de

    Contact:
    Lutz Kiesewetter
    Head of Corporate Communications & Investor Relations
    Telefon: 0049 69 74 30 46 396
    Telefax: 0049 69 74 30 46 46

    E-Mail: lutz.kiesewetter@deutsche-familienversicherung.de

    *SOURCE:* DFV Deutsche Familienversicherung
    View source version on accesswire.com:
    https://www.accesswire.com/530470/DFV-Amazon-Alexa-now-with-monthly-payments-and-liability-insurance Reported by Accesswire 11 hours ago.

    0 0

    TransUnion Healthcare findings reveal that hospitals may be leaving millions on the table when their revenue cycle isn’t optimized

    CHICAGO, Dec. 13, 2018 (GLOBE NEWSWIRE) -- A TransUnion Healthcare (NYSE: TRU) analysis found that 30% of self-pay accounts – those patients without health insurance or those that have a patient balance after insurance – will generate more than 80% of the self pay revenue collected by hospitals. TransUnion released this information as part of a campaign to highlight the importance of healthcare insurance discovery.The findings are significant because the number of patients without health insurance increased to more than 12% at the end of 2017. Furthermore, Patient Balances after Insurance (PBAI) have been steadily rising – increasing from 8% of the total bill responsibility in Q1 2012 to 12.2% in Q1 2017.

    Following years of decline since the Affordable Care Act was passed in 2010,^1 the uninsured rate grew from 10.9% in Q4 2016 to 12.2% in Q4 2017. As a result, hospitals are taking a much closer look at cost control measures; however, they still may be missing the most important part of the picture: an optimized revenue cycle which ensures earned revenue becomes paid revenue.

    This presents a clear opportunity for hospitals to obtain revenue from accounts that are most likely to be paid in full. More opportunities may exist on such accounts as between one and five percent of self-pay accounts that are written off as bad debt actually have billable insurance coverage.

    “Re-evaluating a hospital’s current approach can be a challenge for revenue cycle leaders, but it can result in a great reward by maximizing the healthcare providers’ overall return,” said Dave Wojczynski, president of TransUnion Healthcare. “Determining which patients or accounts may present the best opportunities for payment is just one way a healthcare provider can increase their chances of maximizing reimbursements for services rendered.”

    While some hospitals are improving their profitability via cost cutting, new research also shows that optimizing revenue cycle procedures may be of even greater benefit. In 2018, cutting costs was the highest priority for 63% of hospital C-suite executives, according to a Premier survey. Yet, a recent Advisory Board study indicated that the typical 350-bed hospital may be leaving $22 million on the table by focusing on cutting costs over optimizing their revenue cycle.^2

    “It’s important for hospitals to have systems in place that can holistically address both profitability and revenue leakage,” added Wojcyznski.

    TransUnion Healthcare’s Revenue Protection^SM solutions, including its Insurance Discovery solution, help hospitals prevent revenue leakage by engaging patients early, helping to ensure earned revenue gets paid and by optimizing their collection strategies. The company works with more than 1,800 hospitals and health systems and has protected over $4.4 billion in net revenue to date for its entire client base.

    For additional information about TransUnion Healthcare or Insurance Discovery, please click here.

    *About TransUnion Healthcare*
    TransUnion Healthcare, a wholly owned subsidiary of credit and information management company TransUnion, is a trusted provider of Revenue Protection^SM solutions that help providers collect more cash up front and throughout the revenue cycle, and identify and maximize reimbursement opportunities to reduce bad debt. By leveraging our data assets, market-leading revenue cycle management technologies, and deep insights into consumer financial behavior, our customers are better enabled to reduce uncompensated care, engage patients early and improve cash flow. www.transunionhealthcare.com

    *About TransUnion (NYSE: TRU)
    *Information is a powerful thing. At TransUnion, we realize that. We are dedicated to finding innovative ways information can be used to help individuals make better and smarter decisions. We help uncover unique stories, trends and insights behind each data point, using historical information as well as alternative data sources. This allows a variety of markets and businesses to better manage risk and consumers to better manage their credit, personal information and identity. Today, TransUnion has a global presence in more than 30 countries and a leading presence in several international markets across North America, Africa, Latin America and Asia. Through the power of information, TransUnion is working to build stronger economies and families and safer communities worldwide.

    We call this Information for Good^SM.

    http://www.transunion.com/business

    *Contact

    *       Dave Blumberg
    TransUnion

    *E-mail
    *   david.blumberg@transunion.com

    *Telephone*   312-972-6646

    ^1 https://www.cbsnews.com/news/more-americans-are-going-without-health-insurance/

    ^2 https://www.advisory.com/research/financial-leadership-council/at-the-margins/2017/06/22-million-opportunity Reported by GlobeNewswire 10 hours ago.

    0 0

    Dublin, Dec. 13, 2018 (GLOBE NEWSWIRE) -- The "Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies" report has been added to *ResearchAndMarkets.com's* offering.Pediatric Vaccine Market is projected to exceed US$ 48 Billion by the year 2024

    Increasing government and non-government funding for the development of new vaccines, along with raising awareness about the benefits of vaccination, is certainly expected to positively drive the market growth in the coming years. In order to cut the healthcare expenses, governments have been making continuous efforts to reduce the cost of patient immunization through various vaccination programs funded by government or non-government health authorities. For example; several countries have included Children Vaccination Programs, which offers vaccines to children who lack health insurance or one who cannot afford the cost of vaccination.

    Growing prevalence of chronic diseases is another major market driver, driving the market of infant (pediatric) vaccines. The immune system is not fully developed in infants, hence they are at a higher risk of contracting severe diseases and so, vaccination plays a significant role in their prevention.According to WHO; effective immunization activities have had a major impact on reducing measles deaths. It is found that measles vaccination prevented an estimated 20.4 million deaths across the globe. Global measles deaths have decreased by 84% from an estimated 550,100 in 2000 to 89,780 in 2016.

    *Nearly 650 Million Vaccines Doses will be administered in Pediatrics (Infants) by the year 2024*

    It is estimated that by the year 2024, the doses of vaccines administered will reach nearly 650 Million. The number of vaccine doses is expected to grow considerably during the forecast period due to growing awareness among the parents about the benefits of vaccines and also the developing countries around the world that now have included a number of vaccines to their national immunization programme as per WHO recommendations, which indeed will drive the pediatric vaccine market in recent years.

    *Company Analysis:*

    GlaxoSmithKline, Merck, Sanofi, and Pfizer are some of the top companies that deal efficiently with vaccine business globally. These companies have been studied thoroughly in the report.*Key Topics Covered:**1. Research Findings*

    *2. Pediatric (Infant) Vaccines Market (2011 - 2024)*

    *3. Market & Numbers Share - Pediatric Vaccines*
    3.1 Pediatric Vaccine Market Share
    3.2 Pediatric Vaccinated Population Share
    3.3 Pediatric Doses of Vaccines Administered Share
    3.4 Vaccine Companies Market Share

    *4. Pediatric Vaccinated Numbers*

    *5. Pediatric Doses of Vaccines Administered*

    *6. Disease wise - Pediatric (Infants) Vaccines Market (2011 - 2024)*
    6.1 Influenza
    6.2 MMR (Measles, Mumps, and Rubella Vaccine)
    6.3 Pneumococcal
    6.4 Meningococcal
    6.5 Hepatitis
    6.6 DTaP
    6.7 Haemophilus Influenzae Type B (HIB)
    6.8 Combos (Combination)
    6.9 Polio
    6.10 Rotavirus
    6.11 Varicella

    *7. Disease wise - Numbers of Vaccinated Pediatric (Infants) (2011 - 2024)*
    7.1 Influenza
    7.2 MMR
    7.3 Pneumococcal
    7.4 Meningococcal
    7.5 Hepatitis
    7.6 DTaP
    7.7 Hib (Haemophilus Influenzae Type B)
    7.8 Combos (Combination Vaccines)
    7.9 Polio
    7.10 Rotavirus
    7.11 Varicella

    *8. Disease wise - Doses of Vaccines Administered in Pediatric (Infants) (2011 - 2024)*
    8.1 Influenza
    8.2 MMR
    8.3 Pneumococcal
    8.4 Meningococcal
    8.5 Hepatitis
    8.6 DTaP
    8.7 Hib (Haemophilus Influenzae Type B)
    8.8 Polio
    8.9 Rotavirus
    8.10 Varicella

    *9. Disease wise - Immunization Profile*
    9.1 Immunization Coverage (%) in Infants
    9.2 Global Immunization Profile
    9.3 Regional Immunization Profile
    9.3.1 Measles - Number of Reported Cases
    9.3.2 Mumps - Number of Reported Cases
    9.3.3 Rubella - Number of Reported Cases
    9.3.4 Rubella (CRS) - Number of Reported Cases
    9.3.5 Diphtheria - Number of Reported Cases
    9.3.6 Tetanus (Neonatal) - Number of Reported Cases
    9.3.7 Tetanus (Total) - Number of Reported Cases
    9.3.8 Pertussis - Number of Reported Cases
    9.3.9 Polio - Number of Reported Cases
    9.3.10 Yellow Fever - Number of Reported Cases
    9.3.11 Japanese encephalitis - Number of Reported Cases

    *10. Vaccines Key Players Sales (2011 - 2024)*
    10.1 GlaxoSmithKline, plc.'s Vaccines Sales
    10.2 Merck & Co. Vaccines Sales
    10.3 Sanofi Pasteur's Vaccines Sales
    10.4 Pfizer, Inc.'s Vaccines Sales
    10.5 Global - Other Companies Vaccines Sales

    *11. Vaccines - Products and Pipeline*
    11.1 GSK Vaccine Product Pipeline
    11.2 Merck Vaccine Product Pipeline
    11.3 Sanofi Vaccine Product Pipeline
    11.4 Pfizer Vaccine Product Pipeline

    *12. Top Mergers and Acquisitions in the Vaccine Industry*

    *13. Vaccines and Regulator's Interventions*
    13.1 Making and Meeting Standards of Quality and Safety
    13.2 Vaccine Funding

    *14. Vaccine Market Drivers*
    14.1 Inclusion in National Immunization Schedule
    14.2 Growing Immunization Coverage for HPV Vaccines
    14.3 Increase in Prevalence of Infectious Diseases
    14.4 Global Immunization Vision and Strategy (GIVS)
    14.5 GAVI Model Fuelling Vaccine Manufacturers
    14.5.1 The Partnership Model
    14.5.2 The Business Model
    14.6 Increasing Vaccine Availability in United States
    14.7 The Vaccine Safety Data link Project
    14.8 The Vaccine Injury Compensation Program
    14.9 Transforming of Vaccine Technologies
    14.10 Global Vaccine Action Plan by WHO (2011 - 2020)
    14.11 Continuous Focus on Effective Communication Strategies

    *15. Vaccines Market Challenges*
    15.1 Hurdles to Optimal use of Licensed Vaccines
    15.1.1 Technical Obstacles
    15.1.2 Economic Obstacles
    15.1.3 Cultural Obstacles
    15.2 Complexity of Vaccine Development & Approval System Thwarts Product Development
    15.2.1 Legal Obstacles
    15.2.2 General Technical Barriers
    15.2.3 Economic Barriers
    15.2.4 Regulatory Barriers
    15.3 Shortening the Timeline for Vaccine Development
    15.4 Refusal/Resistance to Vaccination
    15.4.1 Vaccine Adverse Event Reporting System
    15.5 Vaccine Shortages and Delays
    15.6 Obstacles in Vaccine Research & Development
    15.7 Barriers to New Entrants in the Vaccines Market*Companies Mentioned *· GlaxoSmithKline
    · Merck
    · Pfizer
    · Sanofi

    For more information about this report visit https://www.researchandmarkets.com/research/59p9vg/global_pediatric?w=12

    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Vaccines, Liver and Kidney Disorders Drugs , Pediatrics Reported by GlobeNewswire 10 hours ago.

    0 0

    Anyone who wants to enroll in the Affordable Care Act marketplace for health insurance in 2019 needs to do so by the end of the day Saturday, Dec. 15.

     
     
     
     
     
     
     
      Reported by azcentral.com 6 hours ago.

    0 0

    DC-based telecommunications company celebrates recognition for creating a positive, welcoming company culture with 2018 Best in Biz Awards win.

    Arlington, Virginia (PRWEB) December 13, 2018

    Allied Telecom Group has been named a silver winner for “Best Place to Work” in Best in Biz Awards, the only independent business awards program judged each year by prominent editors and reporters from top-tier publications in North America.

    Allied’s nomination was centered around recent enhancements to the company’s culture and benefits, often leveraging technology to facilitate new programs. In the past year, Allied launched a peer recognition tool that allows employees to send electronic “micro-bonuses” to one another, encouraging public recognition for great work, as well as an employee engagement tool that displays a company channel on screens throughout the office, and a performance management tool that automates and streamlines Allied’s employee review process. Additionally, Allied added several benefits to support employees’ health and wellness – including an HSA option with an employer contribution toward health insurance premiums. Aiming to compensate in the top quadrant of its industry, Allied also embarked upon an extensive salary benchmarking process in 2017, ensuring employees are compensated competitively relative to industry peers.

    Other company culture achievements highlighted in Allied’s Best in Biz nomination include a fully funded in-office Weight Watchers program to support employees seeking a healthier lifestyle. During the first twelve weeks of the program, participants collectively lost 268 pounds! Allied also initiated an annual “team appreciation” event in December, encouraging employees to publicly thank team members who supported them throughout the year.

    Each year, Best in Biz Awards’ entrants span the spectrum, from some of the most recognizable global brands to the most innovative local start-ups. The 8th annual program proved to be a particularly tough competition, garnering close to 700 entries from an impressive array of public and private companies of all sizes and from a variety of geographic regions and industries in the U.S. and Canada.

    “It’s so rewarding to see the efforts made by our leadership team and Human Resources department to improve Allied’s company culture recognized with a Silver award from Best in Biz Awards,” said Ashley Laporte, Allied’s Director of Human Resources. “Our people are our greatest asset, and we’ve worked hard to create benefits and implement programs that attract the top talent in the industry and to build a culture that keeps our team members happy and thriving at work.”

    Since 2011, winners in Best in Biz Awards have been determined based on scoring from independent judging panels deliberately composed each year of prominent editors and reporters from some of the most respected newspapers, TV outlets, and business, consumer, technology and trade publications in North America. Structured in this unique way, Best in Biz Awards is able to best leverage its distinguished judges’ unparalleled expertise, experience and objectivity to determine award winners from among the hundreds of entries. The 2018 judging panel included, among others, writers from Associated Press, Consumer Affairs, eWeek, Forbes, New York Post, New York Times, and Wired.

    For a full list of gold, silver and bronze winners in Best in Biz Awards 2018, visit: http://www.bestinbizawards.com/2018-winners.

    ABOUT ALLIED TELECOM: Allied is a highly regarded network service provider in the DC Metro, MidAtlantic and Northeast regions. Known best as a “trusted technology partner,” Allied has delivered Internet, data transport, voice, Unified Communications, and cloud connectivity solutions for clients in business, government and the nonprofit sector for more than 20 years. For more information, visit http://www.AlliedTelecom.net.

    ABOUT BEST IN BIZ AWARDS: Since 2011, Best in Biz Awards has made its mark as the only independent business awards program judged each year by a who’s who of prominent reporters and editors selected from top-tier publications from North America and around the world. Over the years, Best in Biz Awards judges have ranged from Associated Press to the Wall Street Journal and winners have spanned the spectrum, from blue-chip companies that form the bedrock of the world economy to local companies and some of the most innovative start-ups. For more information, visit: http://www.bestinbizawards.com. Reported by PRWeb 8 hours ago.

    0 0

    MIAMI, FL, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Novus Acquisition and Development, Corp. (OTC Markets: NDEV), through its wholly owned subsidiary WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, annuity and accident, and, the nation’s first carrier/aggregator offering a cannabis health plan, today announced its plans to file as an Health Maintenance Organization (HMO) in the State of California.Novus Cannabis MedPlan had a positive initial teleconference with the California Department of Managed Health Care (CDMH) regarding filing its Cannabis MedPlan as a Health Maintenance Organization (HMO). Additional follow up reviews and evaluations by CDMH beginning as early as January 2019.

    Novus as an HMO will expand its breadth as health insurance carrier through its developed network of provider(s) such as:

    ·      Physicians (for example, family doctors that write cannabis recommendations),

    ·      Specialists (for example, oncologists and ophthalmologists that recommend cannabis) and,

    ·      Med facilities (for example, clinics and cannabis dispensaries/cultivators)

    Novus Cannabis MedPlan will initiate as an HMO where it will agree to pay cannabis providers specific levels of compensation for a range of services they provide to its patient/members commencing in the State of California. In return for a monthly fee, or premium, patient/members are granted access to providers inside Novus’ cannabis network at no additional cost.

    The value add of this premium structure is three-fold:

    ·      *Patients*: Reduce healthcare costs with likely reimbursement of cannabis meds and services for patient/members.

    ·      *Providers*: As an HMO cannabis network providers benefits by supplying them with more patients. 

    ·      *Employers*: Growing interest in Novus Cannabis MedPlan by many Professional Employment Organizations that want to integrate THC and CBD Plans for their client base in an HMO format. 

    Novus’ Chief Executive Officer Frank Labrozzi, stated, "This is an unprecedented opportunity for Novus and for the cannabis industry to be permitted by the CDMH to file as an HMO that includes cannabis as a benefits package. Since Novus announced it would begin its business model in an ever-evolving cannabis healthcare landscape, we believe we are seizing an opportunity by disrupting the old healthcare model that pits insurers against providers and instead of working directly with them to offer complete integrated care experience. Novus Cannabis MedPlan is the next generation of healthcare that will do away with the annoyance that many of us have experienced in getting traditional and cannabis related healthcare services.”

    As progress is made Novus will keep shareholders updated of its filing as it transpires.   

    *About Novus*

    Novus Acquisition & Development Corp. (NDEV), through its subsidiary WCIG Insurance, provides health insurance and related insurance solutions within the wellness and medical marijuana industries in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business such as, health, property & casualty, life, accident and fixed annuities.

    Novus medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on these press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. Once a push notification is competed the transaction is solely between the state-licensed dispensary and the registered patient.

    The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws, allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes to Novus Medical Group. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

    ·      For more information, please visit: https://bit.ly/2u1NgMh

    ·      For NDEV Financial Filing: https://www.otcmarkets.com/stock/NDEV/filings

    ·      Learn How Insurance Companies Are Evaluated: http://bit.ly/2ddIYva

    *Forward-Looking Statements*

    This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    CONTACT: Contact Information

    Corporate:

    Chairman and CEO

    Frank Labrozzi

    frank@ndev.biz

    855-228-7355

     

    Investors:

    Hayden IR

    hart@haydenir.com

    917-658-7878 Reported by GlobeNewswire 8 hours ago.

    0 0

    LITTLE ROCK – The deadline for uninsured Arkansans to be certain they and their families have health insurance coverage in 2019 through the state’s My Arkansas Insurance Individual Marketplace is Saturday, Dec. 15. Reported by Harrison Daily 6 hours ago.

    0 0

    Some doctors and nurses at the Tamale Teaching Hospital have been extorting monies from patients at the maternity ward in exchange for healthcare which has already been taken care of in the National Health Insurance Scheme (NHIS) programme. Reported by Myjoyonline 6 hours ago.

    0 0

    Apple threw shade at Amazon 'HQ2' calling it a 'beauty contest,' but then it did the exact same thing (AAPL, AMZN)· Apple announced a new campus in Austin, Texas that will support 5,000 employees.
    · Unlike Amazon's HQ2 process, Apple stayed quiet during the selection process, and CEO Tim Cook said he didn't want it to be a "beauty contest."
    · But ultimately Apple did the same thing as Amazon — choosing to expand in a rich and highly-educated area where it already had thousands of employees.

    Some news from Apple this morning: It's expanding! Apple said in a midnight press release that it's building a new campus in Austin, Texas.

    Details about the new Apple office complex include:

    · An investment from Apple of $1 billion.
    · A location in Williamson County, Texas just outside of Austin. 
    · 5,000 employees to start. 
    · Room to grow for as many as 15,000 employees in divisions including research and development, finance, sales, and customer support. 
    · Incentives from Texas include as much as $25 million in taxpayer-funded grants, and a 15-year property tax abatement possibly worth tens of millions of dollars, according to the Austin Statesman. 

    It's the new campus that Apple teased back in January. "The company plans to establish an Apple campus in a new location, which will initially house technical support for customers. The location of this new facility will be announced later in the year," Apple said in press release. 

    Apple CEO Tim Cook tried to draw contrasts between Apple's search for a new location and Amazon's "HQ2" contest, which drew international headlines. 

    “We’re not doing a beauty contest kind of thing,” Cook said in March. “That’s not Apple.”



    Apple CEO Tim Cook on Amazon’s contest for its second headquarters location: “We’re not doing the beauty contest. That’s not Apple.” #RevolutionCHI pic.twitter.com/TAKZDx3wmO

    — Recode (@Recode) March 28, 2018


    Apple was drawing a contrast between Amazon's publicity-heavy approach, and Apple, which put out a press release at 2 a.m. central time. 

    But there's significantly more in common between the two campus selection processes than Apple would like to admit.

    Both companies basically did the same thing. They announced they were building a new office, and got municipalities to come to them with various incentives, grants, and waived taxes — and then ultimately, both companies chose areas that they already had major operations in. 

    Apple's biggest campus outside of Silicon Valley is its existing Austin campus, which is about a mile from this new development. Apple has such deep history in Williamson County that it sparred with elected officials back in 1993 over whether it could offer health insurance and other benefits to same-sex couples that worked at Apple. (Apple ended up getting $1 million in tax incentives to build its first Austin campus.)

    "At 6,200 people, Austin already represents the largest population of Apple employees outside Cupertino," Apple said in its Thursday press release. 

    Apple's new campus process turns out to be pretty similar to Amazon's HQ2 process, in which the company founded by Jeff Bezos got scores of cities and counties to offer it packages of various incentives, only to turn around and choose Queens, New York, and Arlington, Virginia as locations for HQ2 — rich, educated, urban areas where it already had huge operations.

    Ultimately, the difference between the two processes is surface-level. Both tech giants ended up doing the same thing. 

    If there is a difference between the two approaches, it deals with the goals the various companies had for their new offices. Both are growing prodigiously, and would have probably needed new offices anyway to account for their swelling workforces.

    But while Amazon was interested in getting the top incentives packages as well as collecting information to inform its future expansion, Apple's goals were more political.

    Apple first revealed its new campus back in January, as part of an announcement after it had received $38 billion in tax benefits stemming from Republican tax reform.

    In what seemed to be a quid-pro-quo to Republican politicians and President Donald Trump, Apple said in its announcement that it planned to spend $350 billion in the United States and create 20,000 jobs — talking points that Trump and his administration repeated. Tucked into that announcement, Apple said it would announce in 2018 an "Apple campus in a new location."  

    Much of Apple's January announcement was centered around money it would've spent and jobs it would've created anyway — and this new Austin campus is no different. Apple needs more U.S.-based call centers to maintain its high level of customer support, so it would have had to build them eventually.

    By calling its planned expansion in an area which it already employs thousands a "new campus," Apple gained goodwill from politicians and some key tax breaks. 

    Ultimately, that's not too different from what Amazon did. 

    *Got a tip? Contact the author at kleswing@businessinsider.com or Twitter DM. Secure messaging available upon request. *

    *SEE ALSO: Everything I love and hate about the 2018 Mac Mini*

    Join the conversation about this story »

    NOW WATCH: Amazon wants to open 3,000 cashier-less grocery stores — and they'll have a major advantage over their competitors Reported by Business Insider 6 hours ago.

    0 0

    TAMPA, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Health Insurance Innovations, Inc. (NASDAQ:HIIQ), a leading cloud-based technology platform and distributor of affordable individual and family health insurance and supplemental plans, announced that it will host a conference call to provide a business update today Thursday, December 13, 2018 at 1:30 p.m. ET.*Conference Call and Webcast*

    To participate in the call, please dial (877) 451-6152 or (201) 389-0879; the conference ID is 13685916.

    About Health Insurance Innovations, Inc. (HIIQ)

    HIIQ is a market leading cloud-based technology platform and distributor of innovative health insurance products that are affordable and meet the needs of health insurance plan consumers. HIIQ helps develop insurance products through our relationships with best-in-class insurance companies and markets them via its broad distribution network of third party licensed insurance agents across the nation, its call center network and its unique online capability. Additional information about HIIQ can be found at HiiQuote.com. HIIQ’s Consumer Division includes AgileHealthInsurance.com, a website for researching, comparing and purchasing short-term health insurance products online and HealthPocket.com, a free website that compares and ranks all health insurance plans, and uses objective data to publish unbiased health insurance market analyses and other consumer advocacy research.

    Health Insurance Innovations, Inc.:
    Michael Hershberger
    Chief Financial Officer
    (813) 397-1187
    mhershberger@hiiquote.com 

    Investor Contact:
    John Evans
    PIR Communications
    (415) 309-0230
    john@petrusir.com Reported by GlobeNewswire 3 hours ago.

    0 0

    Reported by SeekingAlpha 2 hours ago.

    0 0

    Anchorage, Ala., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Premera Blue Cross Blue Shield of Alaska, through its Premera Social Impact program, today announced $212,000 in grants to four  nonprofit organizations to expand behavioral health facilities and increase access to health care services.

    Premera Social Impact Program, which launched in 2017, focuses on awarding grants to organizations that support behavioral health solutions, particularly in underserved communities. 

    “It is difficult to access services given the weather and transportation issues,” said Paul Hollie, who leads Premera Social Impact. “Promoting access to necessary care is a priority for these nonprofits, as well as for Premera.” 

    Grants were awarded to the following organizations: 

    Abused Women’s AID will receive $100,000 to expand mental health and substance abuse partnerships as well as connect women of color with culturally supportive resources. 

    Anchorage Project Access will receive $20,000 to expand its outreach services for individuals who experience mental illness, homelessness and other health conditions. APA works to improve health equity by providing trauma informed care to highly vulnerable low-income individuals. by helping them access health insurance and/or donated health care through extensive partnerships with local health care and homeless service providers.

    My House, in Wasilla, will receive $25,000 to help teens struggling with homelessness and addiction. The program operates a café, thrift shop and drop-in center for youth in need.

    NAMI Anchorage will receive $67,000 to launch a program to make support groups accessible through online offerings. This program aims to connect NAMI to families who are underserved due to barriers like transportation, childcare, access challenges or caregiver responsibilities. The nonprofit’s mission is to provide support, education, and advocacy for individuals affected by mental illness, their families, friends, and community.

    To learn more about Premera Social Impact, read the company’s community giving report.

    About Premera Blue Cross Blue Shield of Alaska
    Premera Blue Cross Blue Shield of Alaska, which has operated in Alaska since 1952, is a not-for-profit, independent licensee of the Blue Cross Blue Shield Association. Premera and its family of companies provide comprehensive health benefits and tailored services to approximately 2 million people, from individuals to Fortune 100 companies.

    CONTACT: Bo Jungmayer
    Premera Blue Cross
    425-921-0717
    bo.jungmayer@premera.com Reported by GlobeNewswire 25 minutes ago.